semaglutide and fatty liver disease Why are GLP-1 agonists being used to treat patients with nonalcoholic disease? Focus on Semaglutide 2.4 mg/week

Clinical studies show that patients who discontinue semaglutide without maintaining healthy lifestyle habits typically regain a significant portion of their weight loss

Conclusion The narrative around weight loss has transformed from a singular focus on appearance to a celebration of overall well-being

Patients report reduced interest in high-calorie foods, increased satiety after smaller meals, and a subtle shift in taste perception toward protein-rich options

Indus J Biosci Res

Under the administration's new deal, Novo Nordisk said the lowest doses of Wegovy will cost $149 for a month's supply, if approved, and will extend across all the companys direct-to-patient offerings